Literature DB >> 32202062

Recent Development of Photothermal Agents (PTAs) Based on Small Organic Molecular Dyes.

Shibo Lv1, Yuyang Miao1, Dapeng Liu1, Fengling Song1.   

Abstract

Photothermal therapy (PTT) has attracted great attention due to its noninvasive and effective use against cancer. Various photothermal agents (PTAs) including organic and inorganic PTAs have been developed in the last decades. Organic PTAs based on small-molecule dyes exhibit great potential for future clinical applications considering their good biocompatibility and easy chemical modification or functionalization. In this review, we discuss the recent progress of organic PTAs based on small-molecule dyes for enhanced PTT. We summarize the strategies to improve the light penetration of PTAs, methods to enhance their photothermal conversion efficiency, how to optimize PTAs' delivery into deep tumors, and how to resist photobleaching under repeated laser irradiation. We hope that this review can rouse the interest of researchers in the field of PTAs based on small-molecule dyes and help them to fabricate next-generation PTAs for noninvasive cancer therapy.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  organic photothermal agents; photothermal therapy; supramolecular self-assembly

Mesh:

Substances:

Year:  2020        PMID: 32202062     DOI: 10.1002/cbic.202000089

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  8 in total

1.  A hypoxia-responsive supramolecular formulation for imaging-guided photothermal therapy.

Authors:  Tian-Xing Zhang; Xiaoxue Hou; Yong Kong; Fan Yang; Yu-Xin Yue; Muhammad Raza Shah; Hua-Bin Li; Fan Huang; Jianfeng Liu; Dong-Sheng Guo
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 2.  Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years.

Authors:  Xinyan Hao; Junyong Wu; DaXiong Xiang; Yongyu Yang
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

3.  Chemo-photothermal immunotherapy for eradication of orthotopic tumors and inhibition of metastasis by intratumoral injection of polydopamine versatile hydrogels.

Authors:  Bo Zhuang; Ting Chen; Yueqi Huang; Zhimei Xiao; Yiguang Jin
Journal:  Acta Pharm Sin B       Date:  2021-09-07       Impact factor: 14.903

4.  Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy.

Authors:  Yun Yang; Danrong Hu; Yi Lu; Bingyang Chu; Xinlong He; Yu Chen; Yao Xiao; Chengli Yang; Kai Zhou; Liping Yuan; Zhiyong Qian
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 14.903

Review 5.  Recent Advances in Cyanine-Based Phototherapy Agents.

Authors:  Kubra Bilici; Sultan Cetin; Eda Aydındogan; Havva Yagci Acar; Safacan Kolemen
Journal:  Front Chem       Date:  2021-06-24       Impact factor: 5.221

Review 6.  Design and Application of Near-Infrared Nanomaterial-Liposome Hybrid Nanocarriers for Cancer Photothermal Therapy.

Authors:  Pan Liang; Linshen Mao; Yanli Dong; Zhenwen Zhao; Qin Sun; Maryam Mazhar; Yining Ma; Sijin Yang; Wei Ren
Journal:  Pharmaceutics       Date:  2021-12-03       Impact factor: 6.321

Review 7.  Immunotherapy for Triple-Negative Breast Cancer.

Authors:  Yifeng Cao; Chuyang Chen; Yi Tao; Weifeng Lin; Ping Wang
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

Review 8.  One stone, many birds: Recent advances in functional nanogels for cancer nanotheranostics.

Authors:  Huiyi Wang; Matias L Picchio; Marcelo Calderón
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.